The page is the record's research on the issuer — no analyst, no rating, no view.

Thiogenesis Therapeutics, Corp. (TTI) — research page

CA · ca-cm-kg/TSXV/TTI · as of 2026-11-06

Identity and listing

Thiogenesis Therapeutics, Corp. is listed on the TSXV under ticker TTI, with ISIN CA88410L1022 and LEI 9845006CBA639FFD6454. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Ontario (CA-ON). The listing status is listed, not halted.

fieldvaluesource · read date
nameThiogenesis Therapeutics, Corp.source · 2026-11-06
exchangeTSXVsource · 2026-11-06
tickerTTIsource · 2026-11-06
ISINCA88410L1022source · 2026-11-06
LEI9845006CBA639FFD6454source · 2026-11-06
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionOntario (CA-ON)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 7 filings in the window 2025-11-06 to 2026-11-06, on 7 filing days, of which 1 is an exchange bulletin and 6 are newswire releases. The median gap between filing days is 51.5 days. The latest filing is dated 2026-10-29, a newswire release, 8 days before the record date of 2026-11-06. The TSXV exchange median is 9 filings, a 19-day cadence gap and 17.0 days of latency across 1427 issuers. The Life Sciences sector median is 7.0 filings, a 17.5-day cadence gap and 14 days of latency across 200 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer751.58
exchange median: TSXV (1427 issuers)91917
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-10-29newswire_releaseThiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
2026-10-22newswire_releaseThiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
2026-06-08exchange_bulletinTSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)
2026-04-16newswire_releaseThiogenesis Therapeutics to Present at 2026 Bloom Burton & Co ...
2026-02-02newswire_releaseThiogenesis Therapeutics Announces Investigator-Initiated Study in Nephropathic Cystinosis and Provides Program Update

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record (none found), and its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag reads listed, not halted.

Orderability

Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, as of the chapter date 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and determinable.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page; the coverage state is none found, with a count of 0.

Open research

No openly published research notes were found; the open research state is none found, with a count of 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer has no sealed years on the record. The market's vintage is not sealed, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)
10.2
https://www.marketscreener.com/quote/stock/THIOGENESIS-THERAPEUTICS--136548345 (identity.isin)
10.3
https://api.gleif.org/api/v1/lei-records/9845006CBA639FFD6454 (identity.jurisdiction)
10.4
https://www.tsx.com/en/resource/571 (identity.sector)
10.5
https://mcp.ca-cm-kg.ai/events/TSXV/TTI (the disclosure lines)
10.6
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.7
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.ca-cm-kg.ai/record/TSXV/TTI (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CA88410L1022"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a347ab80bd93b207.